HPS Pharmacies wish to give notice that AstraZeneca are currently experiencing an interruption to the supply of Symbicort® Rapihaler® 100/3 as follows:
Symbicort® Rapihaler® 100/3mcg
Budesonide + Formoterol Fumarate 100mcg+3mcg/inhalation
This temporary shortage is expected to be resolved by the week beginning 24th August 2020.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact AstraZeneca on 1800 805 342, or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates